495 related articles for article (PubMed ID: 33933677)
1. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
Tavares G; Marques D; Barra C; Rosendo-Silva D; Costa A; Rodrigues T; Gasparini P; Melo BF; Sacramento JF; Seiça R; Conde SV; Matafome P
Mol Metab; 2021 Sep; 51():101241. PubMed ID: 33933677
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D.
Vranic M; Ahmed F; Kristófi R; Hetty S; Mokhtari D; Svensson MK; Eriksson JW; Pereira MJ
Endocrine; 2024 Feb; 83(2):378-391. PubMed ID: 37752366
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.
Schwartz SS; Zangeneh F
Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function.
Tavares G; Martins FO; Melo BF; Matafome P; Conde SV
Front Pharmacol; 2021; 12():713418. PubMed ID: 34566639
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.
Davis LM; Michaelides M; Cheskin LJ; Moran TH; Aja S; Watkins PA; Pei Z; Contoreggi C; McCullough K; Hope B; Wang GJ; Volkow ND; Thanos PK
Neuroendocrinology; 2009; 89(2):152-62. PubMed ID: 18984941
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.
de Leeuw van Weenen JE; Parlevliet ET; Schröder-van der Elst JP; van den Berg SA; Willems van Dijk K; Romijn JA; Pijl H
Exp Diabetes Res; 2011; 2011():928523. PubMed ID: 21603181
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D
Wei H; Zapata RC; Lopez-Valencia M; Aslanoglou D; Farino ZJ; Benner V; Osborn O; Freyberg Z; McCarthy MJ
Psychoneuroendocrinology; 2020 Mar; 113():104551. PubMed ID: 31884319
[TBL] [Abstract][Full Text] [Related]
8. Impaired brown adipose tissue is differentially modulated in insulin-resistant obese wistar and type 2 diabetic Goto-Kakizaki rats.
Serdan TDA; Masi LN; Pereira JNB; Rodrigues LE; Alecrim AL; Scervino MVM; Diniz VLS; Dos Santos AAC; Filho CPBS; Alba-Loureiro TC; Marzuca-Nassr GN; Bazotte RB; Gorjão R; Pithon-Curi TC; Curi R; Hirabara SM
Biomed Pharmacother; 2021 Oct; 142():112019. PubMed ID: 34403962
[TBL] [Abstract][Full Text] [Related]
9. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
Ndisang JF; Jadhav A
Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
[TBL] [Abstract][Full Text] [Related]
10. LMO3 reprograms visceral adipocyte metabolism during obesity.
Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
[TBL] [Abstract][Full Text] [Related]
11. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
de Leeuw van Weenen JE; Parlevliet ET; Maechler P; Havekes LM; Romijn JA; Ouwens DM; Pijl H; Guigas B
Biochem Pharmacol; 2010 Jun; 79(12):1827-36. PubMed ID: 20138024
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
13. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
[TBL] [Abstract][Full Text] [Related]
14. Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
Ezrokhi M; Zhang Y; Luo S; Cincotta AH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200262
[TBL] [Abstract][Full Text] [Related]
15. Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
Cincotta AH
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686060
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
Cincotta AH; Tozzo E; Scislowski PW
Life Sci; 1997; 61(10):951-6. PubMed ID: 9296333
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic activity of sarpogrelate and dopamine D
Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term nitrate supplementation on carbohydrate metabolism, lipid profiles, oxidative stress, and inflammation in male obese type 2 diabetic rats.
Gheibi S; Jeddi S; Carlström M; Gholami H; Ghasemi A
Nitric Oxide; 2018 May; 75():27-41. PubMed ID: 29432804
[TBL] [Abstract][Full Text] [Related]
19. The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
Aguayo-Cerón KA; Calzada-Mendoza CC; Méndez-Bolaina E; Romero-Nava R; Ocharan-Hernández ME
Clin Exp Hypertens; 2020 Oct; 42(7):675-679. PubMed ID: 32478610
[TBL] [Abstract][Full Text] [Related]
20. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
